{
  "pmcid": "12023429",
  "sha256": "361cde1bc9e05381bc0c4deafc0c2383d9d9f4b7ea46a7ad826d6870328b4362",
  "timestamp_utc": "2025-11-09T22:13:16.908555+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.378541033434654,
    "reading_ease": 19.076666666666682,
    "word_count": 235
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Association of Stress Hyperglycemia Ratio with Prognosis in Coronary Artery Bypass Grafting: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "This prospective cohort study included 18,307 patients undergoing isolated CABG at the National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, from January 2013 to December 2021."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the association between SHR and prognosis in coronary artery bypass grafting (CABG) patients."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was a composite of in-hospital death, myocardial infarction, cerebrovascular accident, and reoperation."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "This prospective cohort study included 18,307 patients undergoing isolated CABG at the National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, from January 2013 to December 2021."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The third tertile showed a 10.7% greater risk of MACCEs (HR: 1.107, 95% CI 1.023â€“1.231, P = 0.024)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ClinicalTrials.gov NCT02400125"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}